Cytek Biosciences Inc. is a leading manufacturer and supplier of flow cytometry products and services. Cytek’s compact, affordable instruments and wide ranging support offerings are used by researchers and clinicians all over the world.
Flow cytometry is a powerful analytical tool used for identifying and quantifying cellular characteristics on a cell-by-cell basis up to tens of thousands of cells per second. This technology is used in research and clinical studies with various biomedical and therapeutic applications such as investigating the role of the body’s immune system in fighting cancer, diagnosing leukemia and lymphoma, and detecting minimal residual disease in organ transplant patients. Flow cytometry has many advantages over traditional microscopy since it enables the analysis of a greater number of cells in a fraction of the time.
At Cytek, we are focused on accelerating the adoption of flow cytometry for one simple reason: to fuel scientific discovery. We have leveraged our highly experienced, best-in-the-business team to bring forth an innovative new class of flow cytometry solutions. These solutions deliver deep biological insights at an affordable price, provide high-end capabilities, and bring simplified workflows to more researchers than ever before.
As a company, we also seek to maintain high ethical standards and a culture that values honesty, integrity and transparency in all that we do. Company decisions are driven by what is right for scientific discovery and customer support. We are committed to our employees, to the environment in which we live and to the communities we serve worldwide.
Cytek is headquartered in Fremont, California with branch offices and distribution channels across the globe. For more information, visit www.cytekbio.com.
Flow cytometry is a powerful analytical tool used for identifying and quantifying cellular characteristics on a cell-by-cell basis up to tens of thousands of cells per second. This technology is used in research and clinical studies with various biomedical and therapeutic applications such as investigating the role of the body’s immune system in fighting cancer, diagnosing leukemia and lymphoma, and detecting minimal residual disease in organ transplant patients. Flow cytometry has many advantages over traditional microscopy since it enables the analysis of a greater number of cells in a fraction of the time.
At Cytek, we are focused on accelerating the adoption of flow cytometry for one simple reason: to fuel scientific discovery. We have leveraged our highly experienced, best-in-the-business team to bring forth an innovative new class of flow cytometry solutions. These solutions deliver deep biological insights at an affordable price, provide high-end capabilities, and bring simplified workflows to more researchers than ever before.
As a company, we also seek to maintain high ethical standards and a culture that values honesty, integrity and transparency in all that we do. Company decisions are driven by what is right for scientific discovery and customer support. We are committed to our employees, to the environment in which we live and to the communities we serve worldwide.
Cytek is headquartered in Fremont, California with branch offices and distribution channels across the globe. For more information, visit www.cytekbio.com.
Location: United States, California, Fremont
Employees: 201-500
Phone: +1 877-922-9835
Founded date: 2014
Investors 4
| Date | Name | Website |
| - | 3E Biovent... | 3ebiovc.co... |
| - | F-Prime Ca... | fprimecapi... |
| - | RA Capital... | racap.com |
| 22.05.2026 | Eight Road... | eightroads... |
Mentions in press and media 5
| Date | Title | Description |
| 07.03.2024 | Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions | - |
| 13.02.2023 | Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin | Sale of assets related to Flow Cytometry & Imaging (FCI) Business Unit Acquisition will expand Cytek’s product portfolio to include imaging and menu-based application driven flow cytometry to provide full cell analysis solutions to its ... |
| 07.02.2023 | Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios | New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis Systems Delivering a boost to immuno-oncology and immunotherapy researchers, Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that it has entered into a strategic par... |
| 05.11.2020 | Cytek Biosciences Closes $120M Series D Funding | Cytek Biosciences Inc., a Fremont, Calif.-based provider of cell analysis instrumentation and solutions, closed a $120m Series D funding round. The round was co-led by RA Capital and Hillhouse Capital, with OrbiMed and LYFE Capital also par... |
| 26.09.2018 | Term Sheet — Wednesday, September 26 | THE UNRAVELING Good morning, Term Sheet readers. Paid Content Securing the enterprise without boundaries From ExtraHop The departures make sense given that Social Capital is no longer a venture firm but rather a “technology holding company.... |